Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × Postoperative Period × Clear all

Phase

Phase NA 2 Phase 2 1

Status

Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Cisplatin 244 Carboplatin 172 Oxaliplatin 163 Capecitabine 159 Docetaxel 156 apatinib 152 Paclitaxel 145 Gemcitabine 138 Bevacizumab 134 Radiotherapy 132 camrelizumab 129 Fluorouracil 127 Cyclophosphamide 116 Irinotecan 109 Drug Therapy 93 Etoposide 92 sintilimab 89 S 1 (combination) 77 Leucovorin 73 anlotinib 71 Doxorubicin 70 pembrolizumab 69 toripalimab 66 tislelizumab 66 Pemetrexed 66 Dexamethasone 62 Rituximab 61 Neoadjuvant Therapy 59 Cetuximab 58 Trastuzumab 57

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02075060 2017-04-06

IPOI vs IPOP

Poitiers University Hospital

Phase 2 Unknown

Non-Muscle Invasive Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡